Healthcare -
Biotechnology - NASDAQ - BM
$ 19.83
-0.252 %
$ 1.43 B
Market Cap
-165.25
P/E
KNSA - CASH FROM OPERATIONS
Cash from Operations KNSA - Kiniksa Pharmaceuticals, Ltd.
13.3 M
LAST VALUE
45.10%
2 YEAR CAGR
16.70%
5 YEAR CAGR
0.00%
10 YEAR CAGR